Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Wolf

Showing results (231-240 of 384) with videos related to

Pageof 39
Sort By:
Retina (Philadelphia, Pa.)|September 9, 2025
Evaluating Posterior Vitreous Detachment Annotation Consistency on OCT Scans in Patients with Disease of the Vitreomacular InterfaceLorenzo Ferro Desideri, Nina Eldridge, Nicola Sagurski, et al.
Analytical Chemistry|March 15, 2012
Consensus structure elucidation combining GC/EI-MS, structure generation, and calculated propertiesEmma L Schymanski, Christine M J Gallampois, Martin Krauss, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 15, 2019
Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)Ursula Schmidt-Erfurth, José Garcia-Arumi, Bianca S Gerendas, et al.
Ophthalmology|May 25, 2019
ReplyGiovanni Staurenghi, Timothy Y Y Lai, Paul Mitchell, et al.
Ophthalmology|May 25, 2019
ReplyGiovanni Staurenghi, Timothy Y Y Lai, Paul Mitchell, et al.
Ophthalmology|October 20, 2015
Scheduled versus Pro Re Nata Dosing in the VIEW TrialsGisbert Richard, Jordi Monés, Sebastian Wolf, et al.
Retina (Philadelphia, Pa.)|February 18, 2021
ASSESSMENT OF EARLY CHANGES IN SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AFTER INITIATION OF TREATMENT WITH INTRAVITREAL AFLIBERCEPT (EYLEA) OVER A 12-WEEK PERIOD FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Multicenter French Study (START)Jean-François Korobelnik, Eric H Souied, Hassiba Oubraham, et al.
Ocular Immunology and Inflammation|April 18, 2013
Detection of Chlamydia and complement factors in neovascular membranes of patients with age-related macular degenerationUte E K Wolf-Schnurrbusch, Roberto Hess, Florian Jordi, et al.
Ophthalmology|January 27, 2018
Efficacy and Safety of Ranibizumab 0.5 mg for the Treatment of Macular Edema Resulting from Uncommon Causes: Twelve-Month Findings from PROMETHEUSGiovanni Staurenghi, Timothy Y Y Lai, Paul Mitchell, et al.
NPJ Genomic Medicine|September 14, 2020
Associations of the intestinal microbiome with the complement system in neovascular age-related macular degenerationDenise C Zysset-Burri, Irene Keller, Lieselotte E Berger, et al.
Pageof 39

Showing results (231-240 of 384) with videos related to

Sort By:
Pageof 39
Retina (Philadelphia, Pa.)|September 9, 2025
Evaluating Posterior Vitreous Detachment Annotation Consistency on OCT Scans in Patients with Disease of the Vitreomacular InterfaceLorenzo Ferro Desideri, Nina Eldridge, Nicola Sagurski, et al.
Analytical Chemistry|March 15, 2012
Consensus structure elucidation combining GC/EI-MS, structure generation, and calculated propertiesEmma L Schymanski, Christine M J Gallampois, Martin Krauss, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|August 15, 2019
Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA)Ursula Schmidt-Erfurth, José Garcia-Arumi, Bianca S Gerendas, et al.
Ophthalmology|May 25, 2019
ReplyGiovanni Staurenghi, Timothy Y Y Lai, Paul Mitchell, et al.
Ophthalmology|May 25, 2019
ReplyGiovanni Staurenghi, Timothy Y Y Lai, Paul Mitchell, et al.
Ophthalmology|October 20, 2015
Scheduled versus Pro Re Nata Dosing in the VIEW TrialsGisbert Richard, Jordi Monés, Sebastian Wolf, et al.
Retina (Philadelphia, Pa.)|February 18, 2021
ASSESSMENT OF EARLY CHANGES IN SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AFTER INITIATION OF TREATMENT WITH INTRAVITREAL AFLIBERCEPT (EYLEA) OVER A 12-WEEK PERIOD FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Multicenter French Study (START)Jean-François Korobelnik, Eric H Souied, Hassiba Oubraham, et al.
Ocular Immunology and Inflammation|April 18, 2013
Detection of Chlamydia and complement factors in neovascular membranes of patients with age-related macular degenerationUte E K Wolf-Schnurrbusch, Roberto Hess, Florian Jordi, et al.
Ophthalmology|January 27, 2018
Efficacy and Safety of Ranibizumab 0.5 mg for the Treatment of Macular Edema Resulting from Uncommon Causes: Twelve-Month Findings from PROMETHEUSGiovanni Staurenghi, Timothy Y Y Lai, Paul Mitchell, et al.
NPJ Genomic Medicine|September 14, 2020
Associations of the intestinal microbiome with the complement system in neovascular age-related macular degenerationDenise C Zysset-Burri, Irene Keller, Lieselotte E Berger, et al.
Pageof 39